Clinical Trials Directory

Trials / Completed

CompletedNCT01157468

Catalytic Antibodies and Lupus in Martinique

Study of Catalytic Antibodies in a Cohort Population of Martinique

Status
Completed
Phase
Study type
Observational
Enrollment
200 (actual)
Sponsor
University Hospital Center of Martinique · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

* The Martinique island (French West-Indies) is an area of high prevalence and incidence for Systemic Lupus Erythematosus (SLE), respectively 64,2/ 100000 and 4,7/ 100000. In many cases, this disease concerns Afro Caribbean women, whose auto-antibodies are excessively high; also, organic damages are frequent. The disease can be fatal. * Studies have shown that some cytotoxic auto-antibodies may have a responsibility in the hydrolysing of DNA. This study will focus on the DNA activity and also on the overwhelm hydrolase activity dealing with the Lupus disease in order to measure the link between the disease activity and the catalytic activity. Patients concerned by this study will be Martinique people.

Detailed description

This study will be conducted as an case-control survey. * The first group with patients: 60 SLE patients, 30 patients with a quiescent lupus and 30 patients with an active lupus. Patients that will be included are followed by the University hospital of Fort-de-France. * The second group is the control group: subjects will be recruited by the French organisation responsible for donation of blood. Test will be done at the UMRS 872 laboratory of the INSERM - Laboratory of Immunopathology and Therapeutic immunointervention - in Paris ; two catalytic activities will be tested: the DNase activity and the hydrolase activity. Means to analyse the two activities: digestion of plasmid and Affinity-linked Oligonucleotide Nuclease Assay for DNase activity and hydrolysis of a peptide PFR-MCA for hydrolase activity.

Conditions

Timeline

Start date
2012-01-01
Primary completion
2013-12-01
Completion
2013-12-01
First posted
2010-07-07
Last updated
2016-09-08

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT01157468. Inclusion in this directory is not an endorsement.